Rebecca C. Brady, MD
- Director of Adult Clinical Studies, Vaccine Research Center
- Professor, UC Department of Pediatrics
- rebecca.brady@cchmc.org
- Board Certified
About
Biography
I was inspired to go to college by my parents, who were children of the Great Depression and did not have the financial resources to attend college themselves. In medical school and residency, my mentor physicians encouraged me to choose infectious diseases as a subspecialty.
As an infectious disease physician and director of Adult Clinical Services, I treat each patient as I would want to be treated. Infectious Disease is a small division, so we work closely with our nurses and medical assistants to provide timely and exceptional patient care.
I received the Centers for Disease Control and Prevention Immunization Champion Award for the state of Ohio in 2018. This award was for my efforts in improving immunization rates among Ohio’s children.
In my research, my colleagues and I are looking for ways to improve vaccines for influenza. We are also studying candidate vaccines for SARS-CoV-2, which is the cause of COVID-19 disease.
During my spare time, I enjoy embroidery, and I make my own clothes.
MD: University of Kentucky, Lexington, KY, 1988.
Residency: Internal Medicine/Pediatrics, University of Louisville, Louisville, KY.
Fellowships: Pediatric Infectious Diseases, Children's Hospital Medical Center, Cincinnati, Ohio; Adult Infectious Diseases, University of Cincinnati, Cincinnati, OH.
Certifications: Pediatrics, 1992, recertified 1999; Internal Medicine, 1993; Pediatric Infectious Diseases, 1997; Adult Infectious Diseases, 1997.
Interests
Adult and pediatric infectious disease
Services and Specialties
Infectious Diseases
Interests
Cytomegalovirus and other viral infections
Research Areas
Infectious Diseases
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial. The Journal of Infectious Diseases. 2024; 229:327-340.
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants. npj Vaccines. 2023; 8:98.
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn. Vaccine. 2023; 41:5296-5303.
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults. The Journal of Infectious Diseases. 2023; 228:287-298.
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell Reports Medicine. 2022; 3:100679.
Homologous and Heterologous Covid-19 Booster Vaccinations. The New England Journal of Medicine. 2022; 386:1046-1057.
Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients. The Journal of rheumatology. 2021; 48:1314-1321.
Meningococcal Infections in Children and Adolescents: Update and Prevention.
From the Blog
Brady, Frenck Among Co-Authors of Study on COVID Vax Effectiveness Against Omicron Variant
Rebecca C. Brady, MD, Robert W. Frenck Jr., MD7/21/2022
Brady, Frenck Among Co-Authors of COVID Vax ‘Mix-and-Match’ Study in NEJM
Rebecca C. Brady, MD, Robert W. Frenck Jr., MD1/26/2022
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey